{"disease":{"id":"safety-after-oral-intake","name":"safety after oral intake"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07220889","title":"Single Ascending Dose and Multiple Ascending Dose Evaluation of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MDI-2517 in Healthy Participants","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":52,"lead_sponsor_name":"MDI Therapeutics, Inc.","has_results":false},{"nct_id":"NCT07066839","title":"Chrysin Bioavailability and Safety","phase":"NA","overall_status":"COMPLETED","enrollment_count":18,"lead_sponsor_name":"Isura","has_results":false},{"nct_id":"NCT03530436","title":"Comparison of Curcumin Bioavailability","phase":"NA","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"University of Hohenheim","has_results":false},{"nct_id":"NCT03286777","title":"Increasing the Oral Bioavailability of 6-prenylnaringenin by Micellar Solubilization","phase":"NA","overall_status":"COMPLETED","enrollment_count":6,"lead_sponsor_name":"University of Hohenheim","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}